Tokyo, Japan

Taku Ito

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 1995-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Taku Ito: Innovator in Medical and Optical Technologies

Introduction

Taku Ito is a prominent inventor based in Tokyo, Japan, known for his significant contributions to medical and optical technologies. With a total of seven patents to his name, he has made remarkable advancements in the fields of radioisotope production and motion vector calculation.

Latest Patents

Among his latest patents are methods for producing Ac-225 solutions and medicines utilizing Ac-225 solutions. The method for producing an Ac solution involves several steps, including irradiating a Ra target with particles to generate actinium radioisotopes, dissolving the Ra target, and separating the Ra and Ac contained in the solution. This innovative process ultimately leads to the creation of a medicine that incorporates a conjugate between a chelating agent and a targeting agent. Additionally, he has developed a motion vector calculation device and imaging device that utilize event data from sensors to generate frames and calculate motion vectors based on changes in luminance.

Career Highlights

Taku Ito has worked with notable companies such as Asahi Kogaku Kogyo Kabushiki Kaisha and Pentax Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking technologies.

Collaborations

Some of his notable coworkers include Kiyoshi Araki and Isao Okuda, who have collaborated with him on various projects throughout his career.

Conclusion

Taku Ito's innovative work in the fields of medical and optical technologies showcases his dedication to advancing science and improving healthcare solutions. His patents reflect a commitment to innovation that continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…